OurMind Raises €2.1M ($2.3M) in Seed Round Led by 4impact Capital

Why It Matters

By automating routine paperwork, OurMind directly tackles clinician burnout and growing waiting‑list pressures, offering a cost‑effective solution to a looming healthcare workforce shortage in Europe.

Key Takeaways

• OurMind raised €2.1M (~$2.3M) led by 4impact capital
• Platform used by 300+ practices and 14 Dutch hospitals
• AI automates consultation notes, cutting 2‑3 admin hours daily
• Funding targets burnout reduction and waiting‑list mitigation

Pulse Analysis

The administrative load on clinicians has become a silent crisis, with studies showing a quarter of young doctors in the Netherlands exhibiting burnout symptoms. Generative AI, when embedded in clinical workflows, can transform raw conversation into structured notes, freeing physicians to focus on patient interaction. OurMind’s approach aligns with a broader European push to digitise health services while preserving data privacy, a critical factor given strict GDPR mandates.

OurMind’s product suite began with real‑time transcription of doctor‑patient dialogs, then expanded to pre‑consultation briefing, automated referral handling, and patient outreach. Adoption by more than 300 general practices and 14 hospitals demonstrates early market validation, especially as hospitals grapple with waiting lists that now exceed 150 new referrals per week in some facilities. The €2.1 million injection—backed by 4impact Capital, Invest‑NL, and the EU’s InvestEU fund—provides capital for product refinement, regulatory certifications, and a sales push across the Benelux region.

The investment signals confidence in AI‑driven health‑tech as a lever to mitigate the looming shortage forecasted by the Scientific Council for Government Policy, which expects one in four workers to be needed in healthcare by 2040. If OurMind can reliably shave two to three hours of paperwork per clinician, hospitals stand to lower staff turnover, reduce overtime costs, and improve patient throughput. Success could catalyse further venture interest in European health‑tech, positioning AI as a mainstream tool for sustainable, high‑quality care delivery.

Deal Summary

Amsterdam-based AI healthtech startup OurMind announced a €2.1 million ($2.3 million) funding round to scale its platform. The round was led by 4impact capital with participation from Invest‑NL and the EU’s InvestEU Fund, alongside a group of physicians. The capital will be used to expand its AI‑driven administrative tools for hospitals and clinics.